Rüdiger Eichel

Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Universitätsklinikum Essen A.d.ö.R. is a top-rated hospital located in Essen, Germany. The hospital is part of the Universitätsmedizin Essen hospital network, which includes 15 other subsidiaries such as the Ruhrlandklinik, St. Josef Krankenhaus Werden, Herzchirurgie Huttrop, and Westdeutsche Protonentherapiezentrum Essen. The hospital network employs approximately 11,000 people and has 1,700 beds.

Novozymes Berlin GmbH operates as a research and development company. It focuses on products and processes derived from microbial strains. The company was founded in 2001 and is headquartered in Berlin, Germany.

Helmholtz Zentrum München Deutsches Forschungszentrum engages in the operation of a research institution for environmental health. Its activities include research focusing on the interaction of genetics, environmental factors, and lifestyle as well as the development of strategies and applications for the diagnosis, treatment, and prevention of serious common diseases. The company was founded in 1960 and is headquartered in Neuherberg, Germany.

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.